20 (AIDX) Preferred Shares (2024 - 2025)

20 posted quarterly Preferred Shares of $12040.0 for Q4 2025, up 1829.49% year-on-year from $624.0 in Q4 2024, and up 1829.49% on a QoQ basis from $624.0 in Q4 2024.

20 (AIDX) has 2 years of Preferred Shares data on file, last reported at $12040.0 in Q4 2025.

  • For the quarter ending Q4 2025, Preferred Shares rose 1829.49% year-over-year to $12040.0; the trailing twelve-month figure through Dec 2025 stood at $12040.0 (up 1829.49% YoY), and the FY2025 full-year result was $12040.0, up 1829.49% from the prior year.
  • Preferred Shares for Q4 2025 stood at $12040.0, up from $624.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $12040.0 in Q4 2025 and bottomed at $624.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 20 - - 62,884.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 12,040.00
Dec 31, 2024 624.00